$TRVX #Targovax AS Targovax - ONCOS-102 plus durvalumab trial in spotlight: Targovax has announced that one of the trials with ONCOS-102, which is sponsored by Ludwig Institute for Cancer Research, will be in the spotlight at this year's… https://t.co/ZKFhyIk1hk #equity #stocks https://t.co/3L95koOwwz